CLR Stock Recent News

CLR LATEST HEADLINES

CLR Stock News Image - globenewswire.com

Good Tolerability and Robust Tumor Uptake were Observed in TNBC Animal Models Auger Emitters Offer the Potential Benefit of Enhanced Cytotoxicity, Safety and Ease-of-Use FLORHAM PARK, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that the company has submitted a protocol with the U.S. Food and Drug Administration (FDA) for a Phase 1b Dose Finding study of its Auger emitting radiopharmaceutical, CLR 125, for the treatment of relapsed TNBC.

globenewswire.com 2025 Jun 24
CLR Stock News Image - GuruFocus

So far this year, the stock market is doing exactly what market lore says it should. According to tradition, four things are true about January:

GuruFocus 2023 Jan 23
CLR Stock News Image - Zacks Investment Research

Higher operating and production expenses hurt Continental's (CLR) earnings in Q3.

Zacks Investment Research 2022 Nov 22
CLR Stock News Image - Zacks Investment Research

Continental Resources (CLR) delivered earnings and revenue surprises of -3.36% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research 2022 Nov 02
CLR Stock News Image - Zacks Investment Research

Continental Resources (CLR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research 2022 Oct 24
CLR Stock News Image - Zacks Investment Research

Continental Resources (CLR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Investment Research 2022 Oct 18
CLR Stock News Image - Barrons

The company plans to be acquired by the family of its founder, and its largest independent shareholder says the price doesn't reflect its true value.

Barrons 2022 Oct 17
CLR Stock News Image - Fox Business

The energy billionaire's tender offer is for approximately 58 million shares of Continental's common stock, based on shares outstanding as of Oct. 12.

Fox Business 2022 Oct 17
CLR Stock News Image - InvestorPlace

Continental Resources (NYSE: CLR ) stock is rising higher on Monday thanks to an increased buyout offer from founder Harold Hamm. Hamm is offering to purchase all outstanding shares of CLR stock for $74.28 each.

InvestorPlace 2022 Oct 17
CLR Stock News Image - Investors Business Daily

Harold Hamm, the billionaire founder and chairman of Continental Resources, has upped his offer to take the shale oil giant private.

Investors Business Daily 2022 Oct 17
10 of 50